A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma

Published:2012-03-17 Issue:1 Volume:31 Page:99-107
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Yau Thomas,Cheng P. N.,Chan Pierre,Chan William,Chen Li,Yuen Jimmy,Pang Roberta,Fan S. T.,Poon Ronnie T.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-012-9807-9

Reference22 articles.

1. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543

2. Yau T, Yao TJ, Chan P et al (2008) A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials. Cancer 113:2742–2751

3. Palmer DH, Hussain SA, Johnson PJ (2004) Systemic therapies for hepatocellular carcinoma. Expert Opin Investig Drugs 13:1555–1568

4. Qin S, Bai Y, Ye S et al (2010) Phase III study of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) versus doxorubicin as palliative systemic chemotherapy in advanced HCC in Asian patients. American Society of Clinical Oncology Annual Meeting Chicago. J Clin Oncol 28:15, (suppl; abstr 4008)

5. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment;Biomarker Research;2024-09-03

2. Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes;Biochemical Pharmacology;2024-05

3. Arginine reprograms metabolism in liver cancer via RBM39;Cell;2023-11

4. Arginine Is a Novel Drug Target for Arginine Decarboxylase in Human Colorectal Cancer Cells;International Journal of Molecular Sciences;2023-09-06

5. Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells;EMBO reports;2023-07-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3